Corticosteroids for CAP, influenza and COVID-19: when, how and benefits or harm?
CONCLUSIONS: The use of corticosteroids has been considered as a potential alternative co-adjuvant treatment in patients with pneumonia. In patients with COVID-19, the evidence is quite strong and there is a clear benefit of the use of corticosteroids in those patients presenting severe forms of disease.
PMID: 33568526 [PubMed - in process]
Source: Respiratory Care - Category: Respiratory Medicine Authors: Martin-Loeches I, Torres A Tags: Eur Respir Rev Source Type: research
More News: Coronavirus | Corticosteroid Therapy | COVID-19 | Infectious Diseases | Influenza | Men | Pneumonia | Respiratory Medicine | Septic Shock | Study